diet Methionine-Restricted Diet / NRF2 Cancer Research Results

dietMet, diet Methionine-Restricted Diet: Click to Expand ⟱
Features:
Methionine (MET) restriction (MR) has been shown to arrest cancer growth and sensitizes tumors to chemotherapy.
-Many cancer cells rely heavily on exogenous methionine to sustain rapid growth and proliferation because they often have impaired methionine salvage pathways.
-Methionine contributes to the synthesis of glutathione, a key antioxidant. (Methionine is a precursor of glutathione, a tripeptide that reduces reactive oxygen species.)
-MR diets might influence the redox state of cancer cells, increasing oxidative stress and thereby leading to cell death in metabolically compromised tumor cells.
-Proliferation and growth of several types of cancer cells are inhibited by MR, while normal cells are unaffected by limiting methionine as long as homocysteine is present.
-Methionine restriction is effective when the non-essential amino acid, cysteine, is absent from the diet or media. methionine is the precursor for cysteine which is essential for the formation of GSH.
-Malignant cells lack the enzyme required to recycle homocysteine therefore giving methionine restriction the capacity to alter cancer cells while maintaining normal, healthy cells.

While vegan diets are typically low in methionine, some nuts and legumes (such as Brazil nuts and kidney beans) are rich in methionine.

Foods to avoid for MR diet:
Animal Proteins:
-Red Meat (Beef, Pork, Lamb):
-Poultry (Chicken, Turkey):
-Fish and Seafood:
-Eggs: Both the egg whites and yolks are protein rich.
-Dairy Products: Milk, cheese, and yogurt
Certain Plant Proteins:
-Soy Products:
-Legumes:
Protein Supplements:

Foods Lower in Methionine (Often Favorable on an MR Diet)
Fruits & Vegetables: leafy greens, berries, apples, and citrus fruits.
Grains & Cereals: rice, oats, and barley
Nuts and Seeds: can vary in methionine content.
Alternative Protein Sources: emphasize protein sources with a lower methionine-to-cysteine ratio.

Rank Pathway / Target Axis Direction Primary Effect Notes / Cancer Relevance Ref
1 One-carbon metabolism (methionine cycle → folate cycle coupling) ↓ one-carbon flux (Met/SAM-linked metabolites) Core metabolic constraint Nature study shows dietary MR produces controlled, reproducible changes to one-carbon metabolism that alter cancer outcomes (ref)
2 Nucleotide biosynthesis (purines/thymidylate via one-carbon units) ↓ nucleotide synthesis capacity DNA/RNA synthesis limitation Same MR Nature paper links MR-driven one-carbon changes to pathways needed for proliferation and therapy response (ref)
3 Therapy sensitivity (chemo / targeted one-carbon therapy synergy) ↑ sensitivity / ↑ efficacy Therapeutic potentiation Dietary MR influences outcomes and can enhance responses to standard therapies through one-carbon metabolic rewiring (ref)
4 mTORC1 nutrient sensing (Met/SAM → SAMTOR mechanism) ↓ mTORC1 signaling when Met/SAM low Reduced anabolic growth signaling Mechanistic review: SAMTOR senses SAM (derived from methionine) and, when SAM is low, inhibits mTORC1 signaling (ref)
5 Integrated Stress Response (ISR; ATF4 induction under MR) ↑ ISR / ↑ ATF4 Amino-acid stress adaptation MR activates ISR in TNBC cells (eIF2α phosphorylation; ATF4 and targets up), demonstrating stress signaling engagement under methionine restriction (ref)
6 Glutathione (GSH) / ferroptosis coupling (CHAC1 axis) ↑ CHAC1 / ↓ GSH / ↑ ferroptosis (context-dependent) Redox vulnerability Intermittent dietary methionine deprivation augments tumoral ferroptosis; paper links effect to CHAC1 upregulation (CHAC1 promotes GSH degradation) (ref)
7 Epigenetic methylation capacity (SAM-dependent methylation) ↓ methylation potential (via ↓ SAM availability) Altered gene regulation Review focused on dietary methionine and cancer: MR impacts SAM-dependent methylation processes central to biosynthesis/regulation in tumors (ref)
8 Systemic growth signaling (IGF-1) ↓ IGF-1 Lower systemic pro-growth cue Intermittent MR reduces circulating IGF-1 (healthspan paper, but the endocrine direction is explicit and relevant to tumor growth biology) (ref)
9 Radiation sensitization (clinical feasibility context) ↑ RT sensitivity (preclinical); feasible in humans Translational evidence Phase I pilot: MR diet given concurrently with radiation—supports feasibility/safety; paper states preclinical evidence of MRD sensitizing cancer to RT (ref)
10 In vivo tumor growth ↓ tumor growth / ↓ progression (model-dependent) Demonstrated anti-tumor effect Nature MR paper demonstrates MR can influence tumor outcomes in mouse cancer models (ref)


NRF2, nuclear factor erythroid 2-related factor 2: Click to Expand ⟱
Source: TCGA
Type: Antiapoptotic
Nrf2 is responsible for regulating an extensive panel of antioxidant enzymes involved in the detoxification and elimination of oxidative stress. Thought of as "Master Regulator" of antioxidant response.
-One way to estimate Nrf2 induction is through the expression of NQO1.
NQO1, the most potent inducer:
SFN 0.2 μM,
quercetin (2.5 μM),
curcumin (2.7 μM),
Silymarin (3.6 μM),
tamoxifen (5.9 μM),
genistein (6.2 μM ),
beta-carotene (7.2μM),
lutein (17 μM),
resveratrol (21 μM),
indol-3-carbinol (50 μM),
chlorophyll (250 μM),
alpha-cryptoxanthin (1.8 mM),
and zeaxanthin (2.2 mM)

1. Raising Nrf2 enhances the cell's antioxidant defenses and ↓ROS. This strategy is used to decrease chemo-radio side effects.
2. Downregulating Nrf2 lowers antioxidant defenses and ↑ROS. In cancer cells this leads to DNA damage, and cell death.
3. However there are some cases where increasing Nrf2 paradoxically causes an increase in ROS (cancer cells). Such as cases of Mitochondial overload, signal crosstalk, reductive stress

-In some cases, Nrf2 is overexpressed in cancer cells, which can lead to the activation of genes involved in cell proliferation, angiogenesis, and metastasis. This can contribute to the development of resistance to chemotherapy and targeted therapies.
-Increased Nrf2 expression: Lung, Breast, Colorectal, Prostrate.
Decreased Nrf2 expression: Skine, Liver, Pancreatic.
-Nrf2 is a cytoprotective transcription factor which demonstrated both a negative effect as well as a positive effect on cancer
- "promotes Nrf2 translocation from the cytoplasm to the nucleus," means facilitates the movement of Nrf2 into the nucleus, thereby enhancing the cell's antioxidant and cytoprotective responses. -Major regulator of Nrf2 activity in cells is the cytosolic inhibitor Keap1.

Nrf2 Inhibitors and Activators
Nrf2 Inhibitors: Brusatol, Luteolin, Trigonelline, VitC, Retinoic acid, Chrysin
Nrf2 Activators: SFN, OPZ EGCG, Resveratrol, DATS, CUR, CDDO, Api
- potent Nrf2 inducers from plants include sulforaphane, curcumin, EGCG, resveratrol, caffeic acid phenethyl ester, wasabi, cafestol and kahweol (coffee), cinnamon, ginger, garlic, lycopene, rosemany

Nrf2 plays dual roles in that it can protect normal tissues against oxidative damage and can act as an oncogenic protein in tumor tissue.
– In healthy tissues, NRF2 activation helps protect cells from oxidative damage and maintains cellular homeostasis.
– In many cancers, constitutive activation of NRF2 (often through mutations in NRF2 itself or loss-of-function mutations in KEAP1) leads to an enhanced antioxidant capacity.
– This upregulation can promote tumor cell survival by enabling cancer cells to thrive under oxidative stress, resist chemotherapeutic agents, and sustain metabolic reprogramming.
– Elevated NRF2 levels have been implicated in promoting tumor growth, metastasis, and resistance to therapy in various malignancies.
– High or sustained NRF2 activity is frequently associated with aggressive tumor phenotypes, poorer prognosis, and decreased overall survival in several cancer types.
– While its activation is essential for protecting normal cells from oxidative stress, aberrant or sustained NRF2 activation in tumor cells can lead to enhanced survival, therapeutic resistance, and tumor progression.

NRF2 inhibitors: (to decrease antioxidant defenses and increase cell death from ROS).
-Brusatol: most cited natural inhibitors of Nrf2.
-Luteolin: luteolin can reduce Nrf2 activity in specific cancer models and may enhance cell sensitivity to chemotherapy. However, luteolin is also known as an antioxidant, and its influence on Nrf2 can sometimes be context dependent.
-Apigenin: certain studies to down‑regulate Nrf2 in cancer cells: Dose and context dependent .
-Oridonin:
-Wogonin: although its effects might be cell‑ and dose‑specific.
- Withaferin A

Scientific Papers found: Click to Expand⟱
2272- dietMet,    Methionine restriction - Association with redox homeostasis and implications on aging and diseases
- Review, Nor, NA
*OS↑, *mt-ROS↓, *H2S↑, *FGF21↑, *cognitive↑, *GutMicro↑, *IGF-1↓, *mTOR↓, *GSH↑, *SOD↑, *MDA↓, *NRF2↑, *HO-1↑, *NQO1↑, *GLUT4↑, *Glycolysis↑, *HK2↑, *PFK↑, *PKM2↑, *GlucoseCon↑, *ATF4↑, *PPARα↑, GSH↓, GSTs↑, ROS↑, *neuroP↑,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:


Redox & Oxidative Stress

GSH↓, 1,   GSTs↑, 1,   ROS↑, 1,  
Total Targets: 3

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress

GSH↑, 1,   HO-1↑, 1,   MDA↓, 1,   NQO1↑, 1,   NRF2↑, 1,   mt-ROS↓, 1,   SOD↑, 1,  

Core Metabolism/Glycolysis

FGF21↑, 1,   GlucoseCon↑, 1,   Glycolysis↑, 1,   H2S↑, 1,   HK2↑, 1,   PFK↑, 1,   PKM2↑, 1,   PPARα↑, 1,  

Proliferation, Differentiation & Cell State

IGF-1↓, 1,   mTOR↓, 1,  

Angiogenesis & Vasculature

ATF4↑, 1,  

Barriers & Transport

GLUT4↑, 1,  

Clinical Biomarkers

GutMicro↑, 1,  

Functional Outcomes

cognitive↑, 1,   neuroP↑, 1,   OS↑, 1,  
Total Targets: 23

Scientific Paper Hit Count for: NRF2, nuclear factor erythroid 2-related factor 2
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:292  Target#:226  State#:%  Dir#:2
wNotes=0 sortOrder:rid,rpid

 

Home Page